Status: Closed to recruitment

Location: US

Title: A Phase 1/2a Multicenter, Open-Label, Dose-Escalation, Combination Study of RM-1929 and Photoimmunotherapy in Patients with Recurrent Head and Neck Cancer, Who in the Opinion of Their Physician, Cannot Be Satisfactorily Treated with Surgery, Radiation or platinum chemotherapy

To learn more about this trial, see details at https://clinicaltrials.gov/ct2/show/NCT02422979